Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 14, 2013
Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cellsYuji Sakuma, Shoichi Matsukuma, Yoshiyasu Nakamura, et al.
Life Sciences|November 3, 2004
Long-term induction of beta-CGRP mRNA in rat lungs by allergic inflammationJun Tsukiji, Kazunori Sango, Naoko Udaka, et al.
Translational Lung Cancer Research|November 29, 2023
Impact of RBM10 and PD-L1 expression on the prognosis of pathologic N1-N2 epidermal growth factor receptor mutant lung adenocarcinomaTetsuya Isaka, Yohei Miyagi, Tomoyuki Yokose, et al.
Thoracic Cancer|January 10, 2024
Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma"Naoko Shigeta, Tomoyuki Yokose, Shuji Murakami, et al.
Translational Lung Cancer Research|August 13, 2025
Prognostic implications of MDM2 expression in surgically resected epidermal growth factor receptor mutant lung cancer with pathological lymph node metastasisTetsuya Isaka, Yohei Miyagi, Rika Kasajima, et al.
Lung Cancer (Amsterdam, Netherlands)|July 28, 2010
Recurrent EML4-ALK-associated lung adenocarcinoma with a slow clinical courseShuji Murakami, Tomoyuki Yokose, Haruhiro Saito, et al.
Thoracic Cancer|November 13, 2020
Tissue surface area and tumor cell count affect the success rate of the Oncomine Dx Target Test in the analysis of biopsy tissue samplesDaiji Nemoto, Tomoyuki Yokose, Kayoko Katayama, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2023
Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitorsHidetomo Himuro, Yoshiro Nakahara, Yuka Igarashi, et al.
Thoracic Cancer|May 3, 2024
Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand-1 (PD-L1) expression in surgically resected non-small cell lung cancerNaoko Shigeta, Shuji Murakami, Tomoyuki Yokose, et al.
Frontiers in Immunology|June 1, 2026
Gut microbiome functional pathways outperform taxonomic profiles in predicting immune checkpoint inhibitor response in non-small cell lung cancer: an interpretable machine learning approach with SHAPFeifei Wei, Yoshiro Nakahara, Junya Isobe, et al.
Pageof 13